⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

August 6, 2024Open Access

Supplementary Figure 2 from Anti-EGFR Antibody–Drug Conjugate Carrying an Inhibitor Targeting CDK Restricts Triple-Negative Breast Cancer Growth

Anthony Cheung Alicia M. Chenoweth Annelie Johansson Roman Laddach Naomi Guppy Jennifer Trendell Benjamina Esapa Antranik Mavousian Blanca Navarro‐Llinas Syed Haider Pablo Romero-Clavijo Ricarda M. Hoffmann Paolo Andriollo Khondaker Miraz Rahman Paul Jackson Sophia Tsoka Sheeba Irshad Ioannis Roxanis Anita Grigoriadis David E. Thurston Christopher J. Lord Andrew Tutt Sophia N. Karagiannis

View Full Paper

Ask AI

Bookmark

Share

Abstract

Supplementary Figure 2. Single-cell RNA sequencing analyses of HER2, ER and EGFR in breast cancer.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Cheung et al. (2024) studied this question.

synapsesocial.com/papers/68e5d575b6db64358756af2f https://doi.org/10.1158/1078-0432.26504225.v1

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure 2 from Anti-EGFR Antibody–Drug Conjugate Carrying an Inhibitor Targeting CDK Restricts Triple-Negative Breast Cancer Growth2024
2Supplementary Figure 2 from Anti-EGFR Antibody–Drug Conjugate Carrying an Inhibitor Targeting CDK Restricts Triple-Negative Breast Cancer Growth2024
3Supplementary Figure 2 from Anti-EGFR Antibody–Drug Conjugate Carrying an Inhibitor Targeting CDK Restricts Triple-Negative Breast Cancer Growth2024
4Supplementary Figure 3 from Anti-EGFR Antibody–Drug Conjugate Carrying an Inhibitor Targeting CDK Restricts Triple-Negative Breast Cancer Growth2024
5Supplementary Figure 3 from Anti-EGFR Antibody–Drug Conjugate Carrying an Inhibitor Targeting CDK Restricts Triple-Negative Breast Cancer Growth2024

Supplementary Figure 3 from Anti-EGFR Antibody–Drug Conjugate Carrying an Inhibitor Targeting CDK Restricts Triple-Negative Breast Cancer Growth2024
Supplementary Figure 3 from Anti-EGFR Antibody–Drug Conjugate Carrying an Inhibitor Targeting CDK Restricts Triple-Negative Breast Cancer Growth2024
Supplementary Figure 1 from Anti-EGFR Antibody–Drug Conjugate Carrying an Inhibitor Targeting CDK Restricts Triple-Negative Breast Cancer Growth2024